Brief: PledPharma: Results From Prematurely Closed PledOx POLAR Program
Dec 15 (Reuters) - PledPharma AB (publ) PLED.ST :
* RESULTS FROM THE PREMATURELY CLOSED PLEDOX POLAR PROGRAM
* PLEDOX® DID NOT MEET EFFICACY ENDPOINT IN PREMATURELY
CLOSED
PHASE 3 POLAR PROGRAM
* STRATEGIC NEXT STEPS FOR PLEDOX WILL BE DETERMINED
TOGETHER WITH
SOLASIA
Source text for Eikon: ID:nMFN8XwYZK
Further company coverage: PLED.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1